LY-458202

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLY-458202
Drug Alias NameLY-458202LY458202
ClassificationBiologics
Mechanisms of ActionVitamin K-dependent protein C stimulants
TargetsVitamin K-dependent protein C
Therapy Area/IndicationsShock, Cardiogenic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCorrevio PharmaEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsShock, Cardiogenic

Other Information

ATC CodeN/A
Related LinksN/A